Glassman Wealth Services Nevro Corp Transaction History

Glassman Wealth Services

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$14.18 - $22.31 $340 - $535	-24 Reduced 70.59%	10 $0
Q3 2023 Nov 13, 2023	BUY	$18.22 - $25.85 $619 - $878	34 New	34 $0
Q3 2022 Nov 09, 2022	SELL	$40.66 - $53.03 $121 - $159	-3 Reduced 7.32%	38 $2,000
Q2 2022 Aug 04, 2022	BUY	$40.85 - $77.67 $817 - $1,553	20 Added 95.24%	41 $2,000
Q1 2022 Aug 23, 2022	SELL	$59.95 - $92.06 $179 - $276	-3 Reduced 12.5%	21 $2,000
Q1 2022 Apr 14, 2022	BUY	$59.95 - $92.06 $299 - $460	5 Added 26.32%	24 $2,000
Q4 2021 Feb 14, 2022	BUY	$81.07 - $121.29 $891 - $1,334	11 Added 137.5%	19 $2,000
Q3 2021 Nov 10, 2021	BUY	$101.99 - $166.36 $509 - $831	5 Added 166.67%	8 $1,000
Q1 2020 May 12, 2020	SELL	$70.23 - $144.31 $351 - $721	-5 Reduced 62.5%	3 $0
Q4 2019 Feb 07, 2020	BUY	$76.41 - $117.54 $229 - $352	3 Added 60.0%	8 $1,000
Q1 2019 May 10, 2019	BUY	$35.52 - $62.62 $177 - $313	5 New	5 $0

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $116M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.